Programme
| SCIENTIFIC SESSION 4 – Gene Therapies Chairs: Luigi Naldini, Flora Peyvandi |
|
| 09.00 | Addressing vector immunogenicity in the development of AAV-based gene therapies for bleeding disorders Federico Mingozzi, France |
| 09.30 | Liver-directed lentiviral gene therapy of hemophilia Luigi Naldini, Italy |
| 10.00 | An update on UCL/St Jude Haemophilia studies; successes and obstacles ahead Amit Nathwani, UK |
| 10.30 | Gene therapy in hemophilia A Wing Yen Wong, USA |
| 11.00 | Break & Poster Session |
| SCIENTIFIC SESSION 5 – Von Willebrand factor Chairs: Pier Mannuccio Mannucci, Denisa Wagner |
|
| 11.30 | Von Willebrand factor in ischemic stroke Simon de Meyer, France |
| 12.00 | Interplay between von Willebrand factor, ADAMTS13 and NETs Denisa Wagner, USA |
| SATELLITE SYMPOSIA / LECTURE | |
| 12.30 | Satellite Lecture Sponsored by Roche Haemophilia A: can we raise our treatment expectations? Chair: David Lillicrap, Canada. Speaker: Elena Santagostino, Italy |
| 13.00 | Lunch & Poster Session |
| 14.30 | Satellite Lecture Sponsored by Kedrion-LFB How to choose FVIII products in newly treated patients with severe hemophilia A: before and after SIPPET Chair: Johannes B. Oldenburg, Germany. Speaker: Pier Mannuccio Mannucci, Italy |
| 15.00 | Satellite Symposium Sponsored by Shire Recombinant von Willebrand Factor: An Innovative Therapeutic Option for Difficult to Control Bleeds |
| 16.00 | Break & Poster Session |
| SCIENTIFIC SESSION 6 – Von Willebrand factor and disease Chairs: Robert Montgomery, Zaverio M. Ruggeri |
|
| 16.30 | Old concepts and new functions of von Willebrand factor: 2017 Zaverio M. Ruggeri, USA |
| 17.00 | Von Willebrand factor regulation and role in disease José Lopez, USA |
| 17.30 | Collagen and von Willebrand factor interactions and beyond Veronica Flood, USA |
| 18.00 | The genetics of von Willebrand disease Ann Goodeve, UK |
| 18.30 | The many faces of thrombocytopenia in von Willebrand disease type 2B Cecile Denis, France |